Coatue reports 0% Hinge Health (HNGE) stake in amended 13G

Rhea-AI Filing Summary

Hinge Health, Inc. received an amended Schedule 13G showing that investment firm Coatue Management, its related funds, and Philippe Laffont now report 0 shares of Class A common stock beneficially owned.

Each reporting person states 0% of the class as of 12/31/2025, confirming ownership of five percent or less of Hinge Health’s outstanding Class A shares.

Insights

Institutional ownership analyst

Coatue and affiliates report 0% Hinge Health ownership.

The filing shows Coatue Management, L.L.C., related vehicles, and Philippe Laffont now report no beneficial ownership of Hinge Health Class A common stock. Each lists 0 shares with 0 voting and dispositive power as of 12/31/2025.

This indicates their reported stake has fallen below the 5% threshold that requires detailed Schedule 13G disclosure. The filing does not describe any specific transactions; it only updates ownership levels and related control and certification information.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

Hinge Health, Inc.

(Name of Issuer)

Class A Common Stock, par value $0.00001

(Title of Class of Securities)

433313103

(CUSIP Number)

12/31/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 433313103

1

Names of Reporting Persons

Coatue Management, L.L.C.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

0.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

0 %

12

Type of Reporting Person (See Instructions)

IA, OO

SCHEDULE 13G

CUSIP No. 433313103

1

Names of Reporting Persons

Philippe Laffont

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

0.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

0 %

12

Type of Reporting Person (See Instructions)

HC, IN

SCHEDULE 13G

CUSIP No. 433313103

1

Names of Reporting Persons

Coatue Growth Fund IV LP

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

0.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

0 %

12

Type of Reporting Person (See Instructions)

PN

SCHEDULE 13G

CUSIP No. 433313103

1

Names of Reporting Persons

Coatue US 70 LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

0.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

0 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Hinge Health, Inc.
(b)	Address of issuer's principal executive offices: 455 MARKET STREET, SUITE 700, SAN FRANCISCO, CA, 94105
Item 2.
(a)	Name of person filing: Coatue Management, L.L.C. Philippe Laffont Coatue Growth Fund IV LP Coatue US 70 LLC
(b)	Address or principal business office or, if none, residence: Coatue Management, L.L.C. 9 West 57th Street New York, New York 10019 Philippe Laffont c/o Coatue Management, L.L.C. 9 West 57th Street New York, New York 10019 Coatue Growth Fund IV LP c/o Coatue Management, L.L.C. 9 West 57th Street New York, New York 10019 Coatue US 70 LLC c/o Coatue Management, L.L.C. 9 West 57th Street New York, New York 10019
(c)	Citizenship: Coatue Management, L.L.C. - Delaware Philippe Laffont - United States of America Coatue Growth Fund IV LP - Delaware Coatue US 70 LLC - Delaware
(d)	Title of class of securities: Class A Common Stock, par value $0.00001
(e)	CUSIP No.: 433313103
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: Coatue Management, L.L.C. - 0 Philippe Laffont - 0 Coatue Growth Fund IV LP - 0 Coatue US 70 LLC - 0
(b)	Percent of class: Coatue Management, L.L.C. - 0% Philippe Laffont - 0% Coatue Growth Fund IV LP - 0% Coatue US 70 LLC - 0%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: Coatue Management, L.L.C. - 0 Philippe Laffont - 0 Coatue Growth Fund IV LP - 0 Coatue US 70 LLC - 0
	(ii) Shared power to vote or to direct the vote: Coatue Management, L.L.C. - 0 Philippe Laffont - 0 Coatue Growth Fund IV LP - 0 Coatue US 70 LLC - 0
	(iii) Sole power to dispose or to direct the disposition of: Coatue Management, L.L.C. - 0 Philippe Laffont - 0 Coatue Growth Fund IV LP - 0 Coatue US 70 LLC - 0
	(iv) Shared power to dispose or to direct the disposition of: Coatue Management, L.L.C. - 0 Philippe Laffont - 0 Coatue Growth Fund IV LP - 0 Coatue US 70 LLC - 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary. Please see Exhibit B attached hereto.
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.	Certifications:
	Not Applicable

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Coatue Management, L.L.C.

Signature:	/s/ Philippe Laffont
Name/Title:	Philippe Laffont, Authorized Signatory
Date:	02/17/2026

Philippe Laffont

Signature:	/s/ Philippe Laffont
Name/Title:	Philippe Laffont
Date:	02/17/2026

Coatue Growth Fund IV LP

Signature:	By: Coatue Growth Fund IV GP LLC, it general partner, By: /s/ Philippe Laffont
Name/Title:	Philippe Laffont, Authorized Signatory
Date:	02/17/2026

Coatue US 70 LLC

Signature:	By: Coatue Management, L.L.C., its investment manager, By: /s/ Philippe Laffont
Name/Title:	Philippe Laffont, Authorized Signatory
Date:	02/17/2026

Comments accompanying signature: * Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his, her or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. To the extent that "ownership of 5 percent or less of a class" was indicated in Item 5, such response only applies to the Reporting Person(s) that indicated elsewhere herein that it beneficially owns five percent (5%) or less of the class.

Exhibit Information

Exhibit A - Joint Filing Agreement Exhibit B - Control Person Identification

FAQ

What does Coatue’s Schedule 13G/A say about Hinge Health (HNGE) ownership?

The amended filing states Coatue Management, its affiliates, and Philippe Laffont now beneficially own 0 Hinge Health Class A shares, representing 0% of the class as of December 31, 2025. They therefore report owning five percent or less of the outstanding shares.

Which entities are reporting on this Hinge Health (HNGE) Schedule 13G/A?

The filing lists Coatue Management, L.L.C., Philippe Laffont, Coatue Growth Fund IV LP, and Coatue US 70 LLC as reporting persons. Each provides its jurisdiction of organization or citizenship and confirms its current Hinge Health Class A ownership.

How many Hinge Health (HNGE) shares does each Coatue reporting person own?

Each reporting person—Coatue Management, Philippe Laffont, Coatue Growth Fund IV LP, and Coatue US 70 LLC—reports 0 shares beneficially owned, with 0 shares for sole or shared voting and dispositive power. This corresponds to 0% of the Class A common stock.

What is the significance of the 5 percent or less disclosure for Hinge Health (HNGE)?

Item 5 notes ownership of five percent or less of the class, meaning the reporting persons no longer hold a stake at or above the 5% threshold. Schedule 13G focuses on significant ownership positions, so falling below that level triggers this updated disclosure.

Who signed the Hinge Health (HNGE) Schedule 13G/A on behalf of the reporting persons?

Philippe Laffont signed individually and as an authorized signatory for Coatue Management, L.L.C. and Coatue Growth Fund IV GP LLC. The signatures, dated February 17, 2026, certify that the ownership information and related details are true, complete, and correct.

Does Coatue claim beneficial ownership of any Hinge Health (HNGE) securities in this filing?

The filing reports 0 beneficially owned shares and includes a statement that each reporting person disclaims beneficial ownership except to the extent of any pecuniary interest. This language limits how their economic interests are treated for securities law purposes.